- Report
- July 2023
- 74 Pages
United States
From €3114EUR$3,500USD£2,733GBP
- Report
- August 2024
- 200 Pages
Global
From €3442EUR$3,869USD£3,022GBP
- Report
- April 2023
- 140 Pages
Global
From €4403EUR$4,949USD£3,865GBP
- Report
- March 2024
- 300 Pages
Global
€4444EUR$4,995USD£3,901GBP
- Report
- August 2023
- 93 Pages
Global
From €3500EUR$4,214USD£3,180GBP
- Report
- October 2023
- 146 Pages
Global
From €3139EUR$3,528USD£2,755GBP
€3692EUR$4,150USD£3,241GBP
The Connected Drug Delivery Devices market is a subset of the Medical Devices industry. It is comprised of products that are used to deliver drugs, such as insulin pumps, inhalers, and auto-injectors. These devices are designed to provide accurate and consistent drug delivery, while also providing real-time data to healthcare providers. Connected Drug Delivery Devices are becoming increasingly popular due to their ability to improve patient outcomes and reduce healthcare costs.
The Connected Drug Delivery Devices market is expected to experience strong growth in the coming years, driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the increasing adoption of digital health solutions.
Some of the major players in the Connected Drug Delivery Devices market include Medtronic, Becton Dickinson, Johnson & Johnson, Novo Nordisk, and Sanofi. Show Less Read more